Analytical Data
-
基因名
SLC30A2
-
简介
The SLC30A2 protein acts as an electrically neutral proton-coupled antiporter, transporting zinc ions into various intracellular organelles. SLC30A2 Protein, Human (sf9, His, MBP, FLAG) is the recombinant human-derived SLC30A2 protein, expressed by sf9 insect cells , with N-MBP, C-Flag, N-8*His labeled tag.
- Application
-
别名
SLC30A2; Zinc transporter 2; ZnT-2; Solute carrier family 30 member 2
-
种属
Human
-
表达系统
Baculovirus
-
标签
N-MBP;C-Flag;N-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BRI3
-
表达区间
E2-D323
-
蛋白长度
Partial
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC30A2, also known as ZnT2 (Zinc Transporter 2), encodes a protein that plays a critical role in the transport of zinc ions across cellular membranes. Zinc is an essential trace element involved in numerous biological processes, including enzyme function, protein synthesis, and immune response. Dysregulation of zinc homeostasis has been implicated in various diseases, including neurodegenerative disorders and cancer. Research on SLC30A2 has gained attention due to its association with mammary gland development and its potential role in breast cancer. In particular, mutations or alterations in the expression of SLC30A2 can lead to abnormal zinc levels, affecting cellular functions and contributing to malignancy. The recombinant protein studies of SLC30A2 provide insights into the structural and functional characteristics of this zinc transporter, facilitating the understanding of its mechanism of action and regulation. Furthermore, investigating the biochemical properties of SLC30A2 can aid in the development of therapeutic strategies aimed at restoring proper zinc balance in affected tissues. The study of SLC30A2 recombinant protein, therefore, is pivotal in elucidating the molecular underpinnings of zinc transport in health and disease, paving the way for future research and potential clinical applications.
